NU SKIN ENTERPRISES ($NUS) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of $0.23 per share, beating estimates of $0.13 by $0.10. The company also reported revenue of $364,490,000, beating estimates of $355,578,580 by $8,911,420.
You can see Quiver Quantitative's $NUS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NU SKIN ENTERPRISES Insider Trading Activity
NU SKIN ENTERPRISES insiders have traded $NUS stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NUS stock by insiders over the last 6 months:
- EMMA S. BATTLE sold 1,693 shares for an estimated $13,086
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NU SKIN ENTERPRISES Hedge Fund Activity
We have seen 101 institutional investors add shares of NU SKIN ENTERPRISES stock to their portfolio, and 113 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC removed 1,164,585 shares (-22.8%) from their portfolio in Q4 2024, for an estimated $8,023,990
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 971,950 shares (+161.0%) to their portfolio in Q4 2024, for an estimated $6,696,735
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. added 819,972 shares (+142.7%) to their portfolio in Q1 2025, for an estimated $5,952,996
- GOLDMAN SACHS GROUP INC added 776,430 shares (+170.5%) to their portfolio in Q4 2024, for an estimated $5,349,602
- PACER ADVISORS, INC. added 630,479 shares (+inf%) to their portfolio in Q1 2025, for an estimated $4,577,277
- MILLENNIUM MANAGEMENT LLC removed 628,462 shares (-48.5%) from their portfolio in Q4 2024, for an estimated $4,330,103
- JANE STREET GROUP, LLC removed 605,764 shares (-65.5%) from their portfolio in Q4 2024, for an estimated $4,173,713
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
